389: CPG Hypermethylation of Adenomatous Polyposis Coli (APC) Promoter is a Candidate Biomarker to Predict Biological Aggressiveness of Localized Prostate Cancer | Zendy

AI Assistant Blog Pricing

389: CPG Hypermethylation of Adenomatous Polyposis Coli (APC) Promoter is a Candidate Biomarker to Predict Biological Aggressiveness of Localized Prostate Cancer

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.